Home » Topics » BioWorld Science

BioWorld Science
RSS

Long-term results reported from Thai study of Remune monotherapy

July 18, 2001

Overall superior safety profile of BMS-232632 vs. older protease inhibitors confirmed

July 18, 2001

Resistance profile of BCH-10618 suggests further development warranted

July 18, 2001

RANTES analogue stimulates HIV replication at high concentrations via the MAPK/ERK pathway

July 18, 2001

Enrollment complete in second pivotal phase III trial of Cidecin

July 18, 2001

Micrologix suspends MBI-853NL development program; focus shifts to later stage products

July 18, 2001

Karo Bio updates collaborative and internal development projects

July 18, 2001

Licensing opportunity from NIH: virus-like particles as unlinked adjuvants

July 18, 2001

Sepracor preparing for NDA submission of insomnia drug candidate

July 17, 2001

HIV protease inhibitors designed at Merck with improved activity against HIV mutants

July 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...